DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence
A podcast by DrugPatentWatch - Fridays
Categories:
160 Episodes
-
Stop paying your staff to make repetitive reports
Published: 4/7/2021 -
Connecting Excipients with Drug Patents – New DrugPatentWatch module
Published: 3/8/2021 -
Say ‘NO’ to Bad Contracts
Published: 2/11/2021 -
DrugPatentWatch featured in Inc Magazine
Published: 2/2/2021 -
Pharmaceutical procurement practice aspects
Published: 1/7/2021 -
Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet
Published: 1/5/2021 -
Indian Pharma—Some Challenges and Acceptances
Published: 12/21/2020 -
Essential Medicines and Patents
Published: 12/15/2020 -
Drug Patent Expirations for the Week of November 29, 2020
Published: 12/3/2020 -
New patent expiration for Cubist Pharms drug ENTEREG
Published: 11/29/2020 -
Thinking of signing your company up for DrugPatentWatch?
Published: 11/10/2020 -
Finding and Evaluating Generic Drug Market Entry Opportunities
Published: 10/6/2020 -
Freedom of Information Act Access to an Investigational New Drug Application
Published: 10/6/2020 -
Finding and Evaluating Generic Market Entry Opportunities
Published: 9/24/2020 -
Getting the most out of pharmaceutical patent-term extensions in Russia
Published: 9/22/2020 -
Switching to DrugPatentWatch
Published: 9/22/2020 -
Government as the First Investor in Biopharmaceutical Innovation
Published: 9/15/2020 -
Bloomberg and Drug PatentWatch: A “Perfect Storm” Affecting Generic Drugs
Published: 9/15/2020 -
Finding hidden treasures in old drugs: the challenges and importance of licensing generics
Published: 9/2/2020 -
Drug Repurposing: An Overview
Published: 8/19/2020
DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery, and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Use cases for the DrugPatentWatch platform include: - Branded pharmaceutical global business intelligence and forecasting - Generic drug and API manufacturer portfolio management - Wholesalers preventing overstock of off-patent drugs - Healthcare payer formulary management and budget management